Average Co-Inventor Count = 3.63
ph-index = 13
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Corsair Pharma, Inc. (27 from 27 patents)
2. Menlo Therapeutics Inc. (10 from 10 patents)
3. Aryx Therapeutics, Inc. (9 from 50 patents)
4. Theron Pharmaceuticals, Inc. (5 from 5 patents)
5. Portola Pharmaceuticals, Inc. (4 from 70 patents)
6. Syntex (u.s.a.) Inc. (3 from 932 patents)
7. Tigercat Pharma, Inc. (3 from 3 patents)
8. Roche Palo Alto LLC (2 from 322 patents)
9. Panorama Research Inc. (2 from 11 patents)
10. Comentis, Inc. (1 from 7 patents)
11. Vyne Therapeutics Inc. (1 from 6 patents)
67 patents:
1. 12365663 - Treprostinil derivative compounds and methods of using same
2. 12071392 - Aminoadamantyl nitrate compounds and their use to treat CNS disorders
3. 11958822 - Treprostinil derivative compounds and methods of using same
4. 11866402 - Treprostinil derivatives and compositions and uses thereof
5. 11802105 - Treprostinil derivatives and compositions and uses thereof
6. 11505535 - Treprostinil derivative compounds and methods of using same
7. 11447442 - Aminoadamantyl nitrate compounds and their use to treat CNS disorders
8. 11407707 - Treprostinil derivatives and compositions and uses thereof
9. 11339139 - Treprostinil derivative compounds and methods of using same
10. 11046666 - Treprostinil derivative compounds and methods of using same
11. 11034645 - Treprostinil derivatives and compositions and uses thereof
12. 11026920 - Use of NK-1 receptor antagonist serlopitant in pruritus
13. 10988435 - Treprostinil derivatives and compositions and uses thereof
14. 10835514 - Dry powder inhaler compositions of 7-azoniabicyclo[2.2.1]heptane derivatives
15. 10759733 - Treprostinil derivatives and compositions and uses thereof